baber/WOPTO huggingface dataset:
Patent NZ-501935-A (NZ)
Title: Vacuum sewer system with transport of sewage in two stages; valve between sanitary unit and container being open while valve downstream of container being closed; and vice versa
Inventor: OLIN HENRY
IPC: E03F7/00
Filed: 1999-12-20
Abstract: In order to reduce noise and air consumption, a vacuum sewer system is disclosed whereby transportation of waste is carried out in two stages. The waste is first transported to container 3 under vacuum, and then to container 21 under further vacuum. Details of operation are disclosed.
Patent NZ-502058-A (NZ)
Title: Isolated mutated nucleic acid molecule for regulation of ovulation rate
Inventor: WILSON THERESA MARY
IPC: C12N15/12
Filed: 1999-12-23
Abstract: An isolated mutated nucleic acid molecule encoding BMP1B receptor polypeptide for use in modulating ovulation in female vertebrates.
Patent NZ-504275-A (NZ)
Title: Inhaler actuator
Inventor: HODSON DARREN
IPC: A61M11/00
Filed: 1998-11-11
Abstract: An actuator for an inhaler for delivering medicament by inhalation, comprising: a main body  comprising a tubular member for receiving a canister containing medicament and having a valve stem extending therefrom; and an outlet assembly, as a part formed separately of the main body, comprising a mouthpiece for guiding medicament to the mouth of a user and a nozzle block for receiving the valve stem of the canister and delivering medicament from the canister into the mouthpiece; wherein at least a part of at least one of the main body and the outlet assembly is configured so as to deform or break on separating the outlet assembly from the main body so as to prevent re-use of the actuator; characterized in that the main body and the outlet assembly are composed of materials having different constitution.
Patent NZ-506202-A (NZ)
Title: Biphasic controlled release delivery system for high solubility pharmaceuticals and method
Inventor: TIMMINS PETER
IPC: A61K9/22
Filed: 1999-03-10
Abstract: A pharmaceutical compositions formulation comprising (1) an inner solid particulate phase, and (2) an outer solid continuous phase in which particles of the inner solid particulate phase are dispersed and embedded, the particles of the inner solid particulate phase comprising (a) a pharmaceutical having a high water solubility; and (b) an extended release material, and the outer solid continuous phase comprising an extended release material. Also described is a method for preparing a biphasic controlled release delivery system which comprises forming an inner solid particulate phase comprising individual particles comprising a pharmaceutical having a high water solubility and an extended release material and mixing the individual particles forming the inner solid particulate phase with an outer solid continuous phase comprising an extended release material to thereby disperse and embed the individual particles forming the inner solid particulate phase in the outer solid continuous phase. Preferably the pharmaceutical is the biguanide antdiabetic agent, metaform.
Patent NZ-507789-A (NZ)
Title: Method and apparatus for selective block processing
Inventor: KUROWSKI KORDIAN
IPC: H04N7/26
Filed: 1999-02-17
Abstract: Methods, devices and systems for embedding and detecting a watermark in a data stream, such as a video stream. A texture criterion is evaluated for each block of the data stream. The texture criterion measures a variation of selected characteristics associated with each element of the data stream, such as luminance and chrominance. Only those blocks that are determined to have at least a predetermined degree of variation in the selected characteristic are selected for embedding of a watermark. By providing the watermark detector with a block selector that evaluates the same texture criterion as was employed in the watermark embedder, the detector attempts detection of the watermark only in those blocks having been determined to have the predetermined degree of variation of the selected characteristic, or greater. By attempting detection only in such blocks, the number of detection computations is decreased and the watermark signal to data stream noise ratio is increased, thereby facilitating detection of even weak watermarks.
Patent NZ-508825-A (NZ)
Title: Use of optically pure (-) norcisapride in the treatment of apnea, bulimia and other disorders
Inventor: RUBIN PAUL D
IPC: A61K31/4468
Filed: 2000-12-12
Abstract: The use of a therapeutically effective amount  of  (-) norcisapride,   or   a  pharmaceutically   acceptable   salt thereof,  substantially free of its  (+)  stereoisomer,  for the  manufacture  of  a  medicament for  treating  irritable bowel syndrome.
Patent NZ-510210-A (NZ)
Title: 4-phenylamino substituted quinazoline or quinoline derivatives useful for treating cytokine mediated diseases or conditions
Inventor: CUMMING JOHN GRAHAM
IPC: C07D405/12
Filed: 1999-09-27
Abstract: An amide derivative or a pharmaceutically acceptable salt or an in vivo cleavable ester thereof has the formula (I) wherein: G is N or CH; R1 is hydroxy, halo, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy, carbamoyl, formyl, sulphamoyl, alkyl, alkenyl, alkynyl, alkoxy, -O-(alkyl)-O-, alkyl-S(O)n-,N-alkylamino, N,N-(alkyl)2amino, N,N-(alkyl)2carbamoyl, alkanoyl, alkoxycarbonyl, alkylcarbamoyl, N-alkylsulphamoyl, N,N-(alkyl)2sulphamoyl, alkanoyloxy, alkanoylamino, alkylsulphonylamino, alkylsulphonyl-N-alkylamino, A-(CH2)p-B- or D-E; R2 and R3 are independently hydrogen, halo, alkyl, alkenyl or alkynyl; R4 is hydrogen, hydroxy, alkyl, alkoxy, amino, N-alkylamino, N,N-(alkyl)2amino, hydroxyalkoxy, alkoxyalkoxy, aminoalkoxy, N-alkylamino-alkoxy, N,N-(alkyl)2amino-alkoxy, cycloalkyl or K-J; R5 is hydrogen, halo, trifluoromethyl, cyano, nitro, amino, hydroxy, alkyl, alkenyl, alkynyl, alkoxy, N-alkylamino or N,N-(alkyl)2amino; m is 1, 2 or 3; n is 0 to 2; q is 0, 1, 2, 3 or 4; and A, B ,D, E, J and K are as defined in the specification with the proviso that: 4-(3-acetamidoanilino)-6,7-dimethoxyquinazoline and 4-(3-benzamidoanilino)-6,7-dimethoxyquinazoline are excluded. The compounds are useful in treating diseases or medical condition mediated by cytokines.
Patent NZ-511235-A (NZ)
Title: Methods and apparatus for forming a beaded can end
Inventor: HOYING CARL W
IPC: B21D51/26
Filed: 1999-09-22
Abstract: A can end is formed from sheet material in a single acting press by blanking a workpiece and holding the workpiece between a blanking punch and a draw pad. The periphery of the workpiece is worked between a knockout and a crown ring to contour a crown. A bead punch advances into the workpiece to form a shell extending from the crown. The bead punch bottoms out on a bead die and collapses to a predetermined position to form a plurality of beads adjacent the shell by flowing a portion of the shell to form the beads while shortening the shell to less than specifications for the can end. The bead punch returns to an uncollapsed position during upstroke of the press to extend the shell to be within specifications. Apparatus for forming a can end in a press includes a fluidly supported die crown ring having an upper surface defining a can end crown contour. A knockout is aligned with the die crown ring for engaging a workpiece upon downstroke of the press to form a crown in the periphery of the workpiece. A punch, mounted to collapse against fluid pressure, forms a shell extending from the crown and presses the workpiece against a bead die to form a plurality of beads adjacent the shell. The punch collapses so that a portion of the shell flows to form the beads and returns to an uncollapsed position during upstroke to extend the shell to meet specifications.
Patent NZ-511787-A (NZ)
Title: A newspaper ejecting device
Inventor: CHRISOSTOMIDIS ANGELO
IPC: B65H19/30
Filed: 2001-05-18
Abstract: A device (11) for ejecting rolled paper from a paper-rolling machine of the type having a pair of paper rolling forks (15,16) is disclosed.  The device has an ejector arm (12) movable between a pre-eject and an ejecting position, a pneumatic or hydraulic cylinder (23) operatively connected to the ejector arm for moving the ejector arm to the ejecting position and means (27) for actuating the cylinder after a predetermined number of rotations of the rolling forks.
Patent NZ-523701-A (NZ)
Title: Apparatus and method of composing a plan of flexible benefits
Inventor: HYMAN ANDREW A
IPC: G06Q10/00
Filed: 2001-07-16
Abstract: A method is disclosed for enabling an employee, selected from a group of employees, to select a set of benefit products from a group of benefit products in order to provide a flexible benefit plan for the employee, whereby the foregoing information is entered into a database on a computer. The method includes inputting data reflecting the characteristics of the employee into a data processing system, on which both a characteristic table from the inputted data relating to the employee and a table of rules for one of the available benefits is constructed. Each rule of the table points to the employee having a particular mix of characteristics relating to the benefit product. The employeeÆs characteristic table is compared with a rule table to develop a corresponding list of the benefit products for the employees flexible benefit plan.
Patent NZ-524904-A (NZ)
Title: Association of the CB1 receptor antagonist and a sibutramine for treating obesity
Inventor: PIOT-GROSJEAN ODILE
IPC: A61K31/135
Filed: 2001-10-01
Abstract: A combination of a CB1 receptor antagonist and of sibutramine, its hydrate or one of its pharmaceutically acceptable salts. This combination is disclosed as being useful for treating obesity.
Patent NZ-525320-A (NZ)
Title: Combinations of immunostimulatory oligonucleotides (CpG), saponin and optionally lipopolysaccharides as potent vaccine adjuvants
Inventor: GARCON NATHALIE
IPC: A61K39/00
Filed: 2001-10-16
Abstract: Adjuvant formulations for use with cancer antigens are provided. The adjuvant comprises a saponin and an immunostimulatory oligonucleotide. Experimental results show that an adjuvant comprising a CpG oligonucleotide and a formulation comprising SD-MPL and QS21 synergistically enhances tumour regression.
Patent NZ-529969-A (NZ)
Title: Controlled release composition comprising lactic acid polymer, and method of producing the same
Inventor: YAMAMOTO KAZUMICHI
IPC: A61P25/28
Filed: 2002-06-28
Abstract: Disclosed is a controlled release composition comprising a physiologically active substance, and a lactic acid polymer having a weight-average molecular weight of 15000 to 50000 in which the content of polymers having molecular weights of 5000 or less is about 5% by weight or less. The composition is used for medicaments for the treatment of prostatic cancer, prostatic hyperplasia, endometriosis, uterine myoma, uterine fibroma, precocious puberty, dysmenorrheal or breast cancer, or as a contraceptive agent
Patent NZ-530000-A (NZ)
Title: Peptidomimetic bridged bicyclic serine protease inhibitors
Inventor: FARMER LUC
IPC: C07K5/117
Filed: 2002-07-11
Abstract: Peptidomimetic compounds of formula (I) which inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease are disclosed, wherein these compounds have a bridged bicyclic moiety at the P2 position, and wherein the variables are as defined in the specification. These compounds act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. Compositions comprising these compounds are suitable either for ex-vivo use or for administration to a patient suffering from HCV infection.
Patent NZ-531830-A (NZ)
Title: Collapsible wheel
Inventor: LIN VINCENT
IPC: B60B19/04
Filed: 2004-03-18
Abstract: A collapsible wheel in which the components of the wheel cannot readily become separated and misplaced includes a hub (1) adapted for rotation about a hub axis (2). A plurality of wheel portions (40) each have a rim portion (3) and a spoke (4i), (4ii), (4iii), 4(iv), 4(v), 4(vi) and an inner end of the spoke being releasable from the hub. Rim fastening means detachably fix the rim portions together to form the rim of the wheel. Hub-connecting means (5) are provided on the inner end of each releasable spoke for retaining the spoke on the hub when the rim portions are disconnected from one another and the wheel portions are rotated to collapse the wheel.
Patent NZ-536186-A (NZ)
Title: Forming fabric comprising flat shaped conductive monofilament used in the production of non-woven fabrics
Inventor: MONNERIE JEAN-LOUIS
IPC: D03D3/00
Filed: 2003-04-23
Abstract: Disclosed is an apparatus for the production of a non-woven web, structure, or article using a spun-bonding process in combination with a forming fabric which is woven having flat CMD yarns, flat MD yarns or both with some or all of such yarns being conductive so as to dissipate static electricity.
Patent NZ-536885-A (NZ)
Title: PRO 1868 polypeptide with homology to A33 antigen protein and its use for suppressing an immune response
Inventor: BOTSTEIN DAVID
IPC: A61P37/04
Filed: 1999-12-01
Abstract: A polypeptide of SEQ ID NO:20 can be used in a method for non-human animals or the manufacture of a medicament for suppressing an immune response, or increasing the number of pancreatic beta-cell precursor cells. (62) Divided Out of 529539
Patent NZ-542920-A (NZ)
Title: 2-Phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
Inventor: LI YINGFU
IPC: A61K31/439
Filed: 2004-03-11
Abstract: Disclosed is a benzenesulfonamide derivative of the formula (I), its tautomeric or stereoisomeric form, or a salt thereof wherein X represents O or S and the rest of the substituents are disclosed within the specification. Also disclosed is a medicament comprising the benzenesulfonamide derivative of the formula (I), its tautomeric or stereoisomeric form, or a physiologically acceptable salt thereof wherein the medicament is a CCR3 antagonist suitable for the treatment and/or prophylaxis of an inflammatory or immunoregulatory disorder of disease.
Patent NZ-544720-A (NZ)
Title: Improvements in or relating to the treatment of pain
Inventor: SMITH CRAIG P
IPC: A61P3/00
Filed: 2002-02-14
Abstract: N-(Pyridinyl)-1H-indol-1-amines of formula (I) provide a unique combination of blocking properties for both the potassium and sodium channels. Particularly disclosed is a use of the compound of formula (I) in the manufacture of a medicament for treating neuropathic pain and chemokine-induced pain (such as arthritic pain) in a patient in need thereof. These compounds are also useful for the treatment of Demyelinating Diseases and Conditions such as, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury and Stroke. The compounds are also useful for Stroke Rehabilitation and the treatment of Bladder Irritation and Dysfunction.
Patent NZ-546260-A (NZ)
Title: Process for producing radioactive-fluorine-labeled compound
Inventor: HIRANO KEIICHI
IPC: C07B59/00
Filed: 2004-11-08
Abstract: An on-column process by which various radioactive-fluorine-labeled compounds can be obtained in a high yield is disclosed, wherein the process comprises a step in which [18O]water containing [18F]fluoride ions is introduced into a column packed with an anion-exchange resin for labeled-compound synthesis to collect the [18F]fluoride ions, a step in which the column is dehydrated, and a step in which a substrate is introduced into the column to cause a displacement reaction between the [18F]fluoride ions collected in the column and a leaving group of the substrate to thereby obtain a radioactive-fluorine-labeled compound, wherein the step of passing carbon dioxide through the column is conducted between the column dehydration step and the substrate introduction step.
Patent NZ-549738-A (NZ)
Title: Vibrational head and assemblies and uses thereof with shuttle operated by magnetic drive
Inventor: PFAHLERT ROGER
Filed: 2005-03-17
Abstract: A vibrational head assembly is disclosed that is suitable for direct or indirect vibrational input into a structure (for example a drill string A). Ends of the shuttle E have electromagnets or rare earth magnets fitted in such an arrangement that when the shuttle E is rotated it pulses the adjacent members that are also fitted with magnets fitted in such a way that would cause the shuttle to reciprocate. The vibrational output is directly or indirectly from the shuttle's affect on the housing and not from the shuttle itself.
Patent NZ-560902-A (NZ)
Title: Herbicidal suspension
Inventor: YOSHII HIROSHI
IPC: A01N25/04
Filed: 2006-02-23
Abstract: Disclosed is a herbicidal suspension comprising (1) a sulfonylurea compound or its salt as a herbicidal component, (2) at least one surfactant selected from the group consisting of an alkoxylated sorbitol fatty acid ester and an alkoxylated sorbitan fatty acid ester, (3) a water-immiscible diluents, and (4) at least one surfactant selected from the group consisting of polyoxyethylene castor oil and polyoxyethylene hydrogenated castor oil.
Patent NZ-566460-A (NZ)
Title: An improved process for the preparation of beta-lactam antibiotic
Inventor: SURULICHAMY SENTHILKUMAR
IPC: C07D477/20
Filed: 2006-09-15
Abstract: Disclosed is a process for the preparation of highly pure sterile Meropenem trihydrate of the formula (I), which comprises the steps of: (a) dissolving the Meropenem or its hydrate salt in water in the presence of base and in the presence or absence of water-miscible organic solvents, (b) optionally filtering through micron filter, (c) adjusting the pH to 4.0 to 7.0, and (d) optionally adding solvent to yield the Meropenem trihydrate of formula (I).
Patent NZ-567600-A (NZ)
Title: A novel transesterification catalyst and a process for the preparation thereof
Inventor: SRINIVAS DARBHA
IPC: C11C3/10
Filed: 2006-10-03
Abstract: Disclosed is a transesterification catalyst having the general formula: Zn3M2(CN)n(ROH).xZnCI2.yH2O wherein R is tertiary-butyl and M is a transition metal ion selected from Co and Cr, x varies from 0 to 0.5, y varies from 3 - 5 and n is 10 or 12. Also disclosed is the use of a catalyst having the general formula Zn3M2(CN)n(ROH).xZnCI2.yH2O wherein R is tertiary-butyl and M is a transition metal ion selected from iron, cobalt and chromium, x varies from 0 to 0.5, y varies from 3 - 5 and n is 10 or 12, for transesterification reactions of cyclic carbonates with alcohols or for the preparation of fatty acid methyl esters by transesterification of a vegetable oil, such as coconut oil, sunflower oil and soybean oil, with methanol. Further disclosed is the process for preparing a catalyst having the general formula: Zn3M2(CN)n(ROH).xZnCI2.yH2O wherein R is tertiary-butyl and M is a transition metal ion selected from Fe, Co and Cr, x varies from 0 to 0.5, y varies from 3 - 5 and n is 10 or 12 transesterification catalyst.
Patent NZ-573335-A (NZ)
Title: Apparatus where light is non-collimated to a pre-determined degree prior to being incident on optical elements
Inventor: RANA HARBINDER
IPC: G02B23/14
Filed: 2007-07-04
Abstract: Disclosed is a viewing apparatus (1) in which the light can be redirected and the field of view can be moved without moving the apparatus (1) itself. The apparatus (1) comprises a first end (8) for receiving incident light from within a field of view (15) and being adapted to produce a focussed image on the image plane at its second end (18). The apparatus (1) further comprises one or more optical elements (10a, 10b, 11a or 11b). The optical elements (10a, 10b, 11a or 11b) may be moved so that the light from anywhere within the field of view of the viewing apparatus (1) can be redirected to the optical axis (4) thus moving the field of view (15) without moving the apparatus (1) itself. The apparatus (1) also comprises a relay lens group (7) at the first end (8). The relay lens group (7) conditions the light such that it is non-collimated to a pre-determined degree prior to it being incident on one or more of the optical elements (10a, 10b, 11a or 11b).
Patent NZ-573620-A (NZ)
Title: Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide comprising the motif dage or dagd
Inventor: TETI GIUSEPPE
IPC: A61K39/095
Filed: 2007-06-12
Abstract: Disclosed is a peptide that is a molecular mimetic of an epitope of Neissera meningtidis serogroup B (MenB) capsular polysaccharide and does not cross-react immunologically with polysialic acid (PSA) of humans, wherein said peptide induces serum bactericidal activity against MenB and comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 6-11 and 13.
Patent NZ-574409-A (NZ)
Title: Mixing device comprising a pipe bend whose internal wall comprises a planar surface located below the inlet opening
Inventor: KOOPMAN CARLOS NICOLAAS JOZEF MARIA
IPC: A47J31/40
Filed: 2007-07-26
Abstract: A mixing device (2) for mixing a liquid such as water, with an instant ingredient to form a beverage is disclosed. The mixing device (2) comprises a mixing chamber (13, 16, and 24) and a rotor (25). The mixing chamber (13, 16, and 24) comprises an inlet chamber (13), a rotor chamber (24) and a pipe bend (16). The inlet opening (29) of the pipe bend (16) extends in the horizontal plane. The rotor (25) is provided in the rotor chamber (24). The internal wall of the pipe bend (16) has, on the side of the outer curve (11), a planar surface (37) which is defined by a first direction and a second direction. The first direction extends in the horizontal direction and the second direction extends at right angles to the first direction, at an angle to the horizontal plane. The planar surface (37) is situated perpendicularly below the inlet opening (29) of the pipe bend (16).
Patent NZ-588373-A (NZ)
Title: Topical cromolyn formulations
Inventor: LIU PUCHUN
IPC: A61K31/609
Filed: 2005-05-19
Abstract: Disclosed is a topical pharmaceutical composition comprising (a) a cromolyn component selected from cromolyn, pharmaceutically acceptable salts thereof, analogs thereof, and any combination of the foregoing, and (b) a delivery agent of the formula (B) or a salt thereof, wherein the variables are as defined in the specification. Said topical pharmaceutical composition may further comprise (a) an excipient, (b) a cream, (c) an ointment base, (d) a viscosity building agent, (e) a moisturizer, (f) a preservative, (g) a dosing vehicle, or (h) any combination thereof; and it can be used for treating a skin condition selected from the group comprising atopic dermatitis and other eczematous disorders, mastocytosis, vernal deratoconjunctivitis, vernal conjunctivitis, vernal keratitis, skin wounds, skin infections, herpes simplex, herpes zoster, vaccinia virus or coxsackievirus, skin burns, decubitus ulcers, open sores, incisions, traumatic damage caused by irradiation of the skin, prevention of keloid scars and other scar tissue, vulvar vestibulitis, interstitial cystitis, vulvar vaginitis or vaginitis dynea, psoriasis, uremic pruritus, hemangioma, allergic rhinitis (hay fever), and "sinus" headaches.
Patent NZ-588875-A (NZ)
Title: Dosage form containing oxycodone and naloxone
Inventor: LEYENDECKER PETRA
IPC: A61P25/04
Filed: 2006-02-28
Abstract: Disclosed is the use of 10 to 40 mg of oxycodone hydrochloride and of 5 to 20 mg naloxone hydrochloride with oxycodone hydrochloride and naloxone hydrochloride being present in a ratio of 2:1 by weight in the manufacture of a controlled release pharmaceutical dosage form for the treatment of moderate to severe pain and reducing the severity of opioid bowel dysfunction syndromes and reducing the incidence of diarrhea as elicited naloxone typical adverse event in a population that is sensitive to naloxone induced diarrhea.
Patent NZ-591312-A (NZ)
Title: Treatment of pediatric acute lymphoblastic leukemia with a CD19 CD3 bispecific single chain antibody construct
Inventor: ZUGMAIER GERHARD
IPC: C07K16/28
Filed: 2009-11-06
Abstract: Disclosed is the use of a CD19xCD3 bispecific single chain antibody construct for the manufacture of a medicament for the treatment, amelioration or elimination of pediatric acute lymphoblastic leukemia (ALL) in a patient.